Globus Medical, Inc. (GMED)

Market Cap	9.98B
Revenue (ttm)	2.52B
Net Income (ttm)	102.98M
Shares Out	137.54M
EPS (ttm)	0.75
PE Ratio	96.73
Forward PE	21.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	737,330
Open	73.06
Previous Close	73.66
Day's Range	70.69 - 73.12
52-Week Range	49.33 - 94.93
Beta	1.19
Analysts	Buy
Price Target	97.09 (+33.83%)
Earnings Date	May 6, 2025

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 5,300
• Stock Exchange: NYSE
• Ticker Symbol: GMED
• Website: https://www.globusmedical.com

Financial Performance

In 2024, Globus Medical's revenue was $2.52 billion, an increase of 60.62% compared to the previous year's $1.57 billion. Earnings were $102.98 million, a decrease of -16.19%.

Analyst Forecast

According to 13 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $97.09, which is an increase of 33.83% from the latest price.

Price Target

$97.09

(33.83% upside)

Analyst Consensus: Buy